Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia

Journal of Histochemistry and Cytochemistry

Volumn 50, Issue 6, 2002, Pages 767-777

  Witmer, Antonella N ^a   Dai, Jiapei ^a   Weich, Herbert A ^a   Vrensen, Gijs F J M ^a   Schlingemann, Reinier O ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Electron microscopy; Endothelial growth factor receptors; Endothelial growth factors; Human; Immunohistochemistry; Monkey; Tissue distribution

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; ENDOTHELIAL GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CONTROLLED STUDY; ENDOTHELIUM; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOID TISSUE; MONKEY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0036289044     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540205000603     Document Type: Article

References (67)

1. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
2. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
3. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation
4. Functions of the VEGF/VEGF receptor system in the vascular system
5. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
6. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
7. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas
8. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
9. Angiogenesis in cancer and other diseases
10. Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis
11. VEGF regulates cell behavior during vasculogenesis
12. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis
13. Vascular endothelial growth factor induces endothelial fenestrations in vitro
14. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors
15. Vascular endothelial growth factor: Molecular and biological aspects
16. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
17. Molecular and biological properties of the vascular endothelial growth factor family of proteins
18. Angiogenesis in cancer, vascular, rheumatoid and other disease
19. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types
20. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease
21. VEGF is required for growth and survival in neonatal mice
22. VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis
23. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas
24. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors
25. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids
26. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
27. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
28. RPE destruction causes choriocapillary atrophy
29. Expression of vascular endothelial growth factor (VEGF) in various compartments of the human hair follicle
30. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system
31. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors
32. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors
33. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
34. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues
35. Endothelial receptor tyrosine kinases involved in angiogenesis
36. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma
37. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: Proposed pathomechanism of vascular proliferation in the affected lymph node
38. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells
39. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration
40. Signal relays in the VEGF system
41. Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype
42. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues
43. Vascular endothelial growth factor is a potential turnout angiogenesis factor in human gliomas in vivo
44. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium
45. Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development
46. Monoclonal antibody-defined human endothelial antigens as vascular markers
47. Monoclonal antibody PAL-E specific for endothelium
48. Vascular expression of endothelial antigen PAL-E indicates absence of blood-ocular barriers in the normal eye
49. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue
50. Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma
51. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
52. In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: Implications for mode of action
53. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney
54. Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: Localization and [125I]VEGF binding sites
55. Regulation of angiogenesis in the endometrium
56. Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes
57. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
58. Expression of vascular endothelial growth factor in digestive neuroendocrine tumours
59. Characterization of the receptors for vascular endothelial growth factor
60. Regulation of angiogenesis via vascular endothelial growth factor receptors
61. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis
62. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey
63. VEGFR-3 in adult angiogenesis
64. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
65. Vascular-specific growth factors and blood vessel formation
66. Control of hair growth and follicle size by VEGF-mediated angiogenesis
67. Time-course expression of vascular endothelial growth factor as related to the development of the retinochoroidal vasculature in rats